DPP4 and heart failure: This review aims to delve into the physiological underpinnings of DPP-4 inhibitors, analyze their clinical efficacy and safety for heart failure patients, explore the unique considerations for special populations, and compare them to other antidiabetic therapies in this high-risk group.